The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Impact of time to treatment initiation (TTI) on survival of patients with newly diagnosed non-small cell lung cancer (NSCLC).

Abdel-Ghani  Azzouqa

No Relationships to Disclose

Ruqin  Chen

Employment - GlaxoSmithKline (I)

Stock and Other Ownership Interests  - GlaxoSmithKline (I); Lilly

Yanyan  Lou

Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer

Sikander  Ailawadhi

Consulting or Advisory Role - Amgen; Celgene; Janssen Biotech; Takeda

Research Funding - Cellectar (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Phosplatin Therapeutics (Inst)

Travel, Accommodations, Expenses - Amgen; Novartis; Takeda

Rami  Manochakian

Consulting or Advisory Role - Takeda